We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
MEROPENEM-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
MEROPENEM-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
meropenem trihydrate
Registration type
New generic medicine
Indication
Meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: